Number Crunch: Life sciences slips from its covid peak
privateequityinternational
2 months ago
25 views
After a surge in interest around the covid-19 pandemic, it has been a mixed picture for life sciences and biotech-focused PE fundraising and capital deployment.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.